Total Payments
$8,426
2024 Payments
$647.76
Companies
31
Transactions
202
Medicare Patients
6,539
Medicare Billing
$934,964
Payment Breakdown by Category
Food & Beverage$5,221 (62.0%)
Consulting$2,328 (27.6%)
Travel$866.89 (10.3%)
Education$10.85 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,221 | 196 | 62.0% |
| Consulting Fee | $2,328 | 2 | 27.6% |
| Travel and Lodging | $866.89 | 3 | 10.3% |
| Education | $10.85 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,763 | 10 | $0 (2023) |
| Medtronic Vascular, Inc. | $1,252 | 9 | $0 (2018) |
| Beckman Coulter, Inc. | $700.00 | 1 | $0 (2019) |
| Medtronic, Inc. | $531.68 | 6 | $0 (2024) |
| Abbott Laboratories | $509.74 | 9 | $0 (2024) |
| Boston Scientific Corporation | $452.68 | 12 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $429.37 | 32 | $0 (2024) |
| Amgen Inc. | $428.48 | 15 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $415.12 | 13 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $325.72 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $647.76 | 33 | Novartis Pharmaceuticals Corporation ($132.38) |
| 2023 | $1,020 | 38 | Abbott Laboratories ($214.01) |
| 2022 | $1,048 | 32 | Medtronic, Inc. ($324.90) |
| 2021 | $904.68 | 38 | Medtronic, Inc. ($183.81) |
| 2020 | $232.49 | 14 | AstraZeneca Pharmaceuticals LP ($57.29) |
| 2019 | $2,619 | 13 | AstraZeneca Pharmaceuticals LP ($1,659) |
| 2018 | $377.83 | 13 | Amgen Inc. ($117.70) |
| 2017 | $1,576 | 21 | Medtronic Vascular, Inc. ($1,175) |
All Payment Transactions
202 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/22/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/05/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $82.62 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/22/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 10/15/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/28/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $14.02 | General |
| 09/12/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $4.80 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/04/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $25.16 | General |
| Category: Not Applicable | ||||||
| 08/26/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: Heart Failure | ||||||
| 08/23/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/22/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $16.91 | General |
| Category: Cardiology | ||||||
| 08/07/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: Not Applicable | ||||||
| 08/06/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/16/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $2.68 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $2.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/28/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $1.20 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/27/2024 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $22.97 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 06/25/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Cardiology | ||||||
| 06/21/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $2.11 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/12/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/11/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $5.72 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/13/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: Cardiology | ||||||
| 05/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/25/2024 | Boston Scientific Corporation | ACUITY Steerable (Device) | Food and Beverage | In-kind items and services | $108.52 | General |
| Category: ACUITY_CRM | ||||||
| 04/19/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $24.58 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 03/20/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $29.11 | General |
| Category: Heart Failure and Hypertension | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 1,902 | 3,867 | $1.2M | $315,783 |
| 2022 | 26 | 1,535 | 2,759 | $744,747 | $226,690 |
| 2021 | 23 | 1,520 | 2,583 | $682,230 | $199,469 |
| 2020 | 22 | 1,582 | 2,644 | $698,416 | $193,023 |
Total Patients
6,539
Total Services
11,853
Medicare Billing
$934,964
Procedure Codes
108
All Medicare Procedures & Services
108 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 219 | 909 | $149,985 | $84,366 | 56.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 167 | 746 | $199,928 | $70,712 | 35.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 111 | 111 | $213,675 | $38,546 | 18.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 157 | 163 | $163,000 | $24,925 | 15.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 124 | 136 | $70,856 | $17,845 | 25.2% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 79 | 316 | $24,690 | $13,422 | 54.4% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 83 | 84 | $43,680 | $12,303 | 28.2% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 110 | 125 | $39,820 | $9,648 | 24.2% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 36 | 37 | $55,500 | $8,315 | 15.0% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 120 | 125 | $48,655 | $6,147 | 12.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 218 | 526 | $42,080 | $5,506 | 13.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 32 | 52 | $19,500 | $4,739 | 24.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 79 | 94 | $27,448 | $4,643 | 16.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 40 | 40 | $12,800 | $4,462 | 34.9% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 66 | 82 | $20,500 | $4,057 | 19.8% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 17 | 21 | $3,528 | $1,354 | 38.4% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 12 | 12 | $3,600 | $934.34 | 26.0% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 11 | 12 | $4,272 | $698.24 | 16.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 81 | 106 | $3,710 | $658.52 | 17.7% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 13 | 25 | $2,000 | $552.23 | 27.6% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 47 | 49 | $6,468 | $479.09 | 7.4% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 16 | 30 | $2,220 | $471.12 | 21.2% |
| 93567 | Injection for imaging of aorta above heart valve with review by radiologist | Facility | 2023 | 16 | 16 | $5,408 | $464.64 | 8.6% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 11 | 12 | $1,500 | $201.76 | 13.5% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 13 | 13 | $1,500 | $169.68 | 11.3% |
About Dr. Haroonur Rashid, MD
Dr. Haroonur Rashid, MD is a Cardiovascular Disease healthcare provider based in Webster, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1710073994.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Haroonur Rashid, MD has received a total of $8,426 in payments from pharmaceutical and medical device companies, with $647.76 received in 2024. These payments were reported across 202 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($5,221).
As a Medicare-enrolled provider, Rashid has provided services to 6,539 Medicare beneficiaries, totaling 11,853 services with total Medicare billing of $934,964. Data is available for 4 years (2020–2023), covering 108 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Webster, TX
- Active Since 10/05/2006
- Last Updated 10/03/2022
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1710073994
Products in Payments
- FARXIGA (Drug) $1,711
- CoreValve Evolut (Device) $1,403
- DXI 800 (Device) $700.00
- ELIQUIS (Drug) $444.22
- Repatha (Biological) $360.42
- COREVALVE EVOLUT R (Device) $324.90
- XARELTO (Drug) $311.44
- LifeVest (Device) $264.01
- ENTRESTO (Drug) $263.32
- CARDIOMEMS (Device) $212.56
- VERQUVO (Drug) $203.60
- LEQVIO (Drug) $166.05
- JARDIANCE (Drug) $162.79
- CAMZYOS (Drug) $158.76
- Allure Quadra RF CRT Pacemaker (Device) $144.53
- WATCHMAN (Device) $141.02
- Occluders (Device) $110.17
- ACUITY Steerable (Device) $108.52
- Flexitouch Plus (Device) $100.45
- Impella (Device) $100.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Webster
Dr. Abdelkader Almanfi, M.d, M.D
Cardiovascular Disease — Payments: $234,505
Cardiovascular Disease $234,505
Ahmad Al-Taweel, Md, MD
Cardiovascular Disease — Payments: $27,015
Cardiovascular Disease $27,015
Bahaeddin Shabaneh, Md, MD
Cardiovascular Disease — Payments: $21,788
Cardiovascular Disease $21,788
Dr. Ishwara Sharma, M.d, M.D
Cardiovascular Disease — Payments: $16,935
Cardiovascular Disease $16,935
Gerard Abreo, Md, MD
Cardiovascular Disease — Payments: $14,242
Cardiovascular Disease $14,242
Dr. Molham Aldeiri, M.d, M.D
Cardiovascular Disease — Payments: $13,972
Cardiovascular Disease $13,972